This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

edited by J. E. S. Olesen, MD, PhD, and Peter Tfelt-Hansen, PhD, 400 pp, $95, Philadelphia, Pa, Lippincott-Raven Publishers, 1997.

Dewey K. Ziegler, MD, Reviewer
Kansas City, Kan

Arch Neurol. 1997;54(10):1199-1200.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This is a volume of 56 chapters, almost all of them quite brief. The first half of the volume relates to the methodological problems in clinical trials of drugs for the treatment of headache. The second half of the volume contains articles concerning effectiveness of sumatriptan, new methods of its administration, and reports of safety and efficacy of a variety of new 5-hydroxytriptamine 1D agonists in the treatment of migraine. The last section of the book is a potpourri of studies of other agents known to be useful, or considered as possibly useful, in the treatment of migraine—salicylates, substance P agonists, and sodium valproate.

There are several excellent aspects to this volume. The initial chapters enlighten the reader on the basics of clinical drug trials—the phases of research in new drugs and the problems of experimental design, such as decisions regarding the use of crossover vs parallel form studies. Several . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?